Hepatitis B Surface Antibody General Clinical Tests
| Test NameMethod | Hepatitis B Surface Antibody, Total Anti- HBs, HBsAb |
| SpecimenRequirements | SerumStable for 7 d at RT and indefinitely at 4° C or – 20°C. |
| Chemical InterfacesIn Vivo Effects | None Found |
| Ref. RangeConventional
International Recommended Units |
Negative Limits of detection: 2-10 IU/L |
| Diagnostic Information | With naturally occurring Hepatitis B infections, anti-HBs usually appears in the serum several weeks after disappearance of HBsAg. The presence of of anti-HBs generally means there is protection against Hepatitis B infection. However, convalescent anti-HBs mall fall below limits of detection. A qualitative finding of >10 IU/L for post vaccine testing is the accepted concentration which confers protection. |
| Remarks | Anti-HBs is now mainly used to assess efficacy of Hepatitis B vaccine but remains an adjunct test along with anti-HBc for determining whether subjects have immunity due to a naturally acquired infection or whether chronic Hepatitis B might exist in an HBsAg negative patient. |
References:
Clinical Guide to Laboratory Tests, third edition.

